Average Co-Inventor Count = 4.74
ph-index = 25
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (285 from 288 patents)
2. Abbott Laboratories Corporation (43 from 4,171 patents)
3. Abbvie Inc. (4 from 822 patents)
4. Other (2 from 831,952 patents)
5. Pic Therapeutics, Inc. (2 from 5 patents)
6. Novartis Ag (1 from 3,912 patents)
7. Elmore Patent Law Group, P.c. (1 from 1 patent)
8. Enata Pharmacueticals, Inc. (1 from 1 patent)
9. Emata Pharmaceuticals, Inc (1 from 1 patent)
10. Enanta Pharmacueticals, Inc. (1 from 1 patent)
11. Abbvie Bahamas Limited (6 patents)
338 patents:
1. 12398147 - Macrocyclic spiropyrrolidine derived antiviral agents
2. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
3. 12358921 - Antiviral heterocyclic compounds
4. 12297209 - Benzodiazepine derivatives as RSV inhibitors
5. 12281140 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
6. 12268694 - Combination pharmaceutical agents as RSV inhibitors
7. 12264159 - Functionalized heterocycles as antiviral agents
8. 12162857 - Antiviral compounds
9. 12157731 - EIF4E inhibitors and uses thereof
10. 12145941 - Heterocyclic antiviral agents
11. 12145942 - Spiropyrrolidine derived antiviral agents
12. 12054493 - Hepatitis B antiviral agents
13. 12018017 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
14. 12011425 - Hepatitis B antiviral agents
15. 12006326 - Antiviral heterocyclic compounds